Report will help you understand the market entry challenges you face and give you the expert advice to overcome them. Couple this with market leading intelligence data and this report is a must have if you’re looking to outcompete your rivals in this expanding and highly profitable market.

1. Opportunities in Human Embryonic Stem Cell
Products
Published: August 2013
Single User PDF: US$ 3495
Corporate User PDF: US$ 5495
Order this report by calling
+1 888 391 5441 or Send an email
to sales@reportsandreports.com
with your contact details and
questions if any.
1© ReportsnReports.com / Contact sales@reportsandreports.com

2. Opportunities in Human Embryonic Stem
Cell Products
Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a
blastocyst, which is a stage reached four to five days post-fertilization. Human embryonic
stem cells are the most pluripotent of all stem cell types and can develop into over 200
different cell types of the human body.
Human embryonic stem cells were first derived from mouse embryos in 1981 by Martin
Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first
successful culturing of embryonic stem cells from non-human primates occurred at the
University of Wisconsin-Madison. Another breakthrough followed at the University of
Wisconsin-Madison in November 1998 when a group led by Dr. James Thomson developed a
technique to isolate and grow hESCs derived from human blastocysts. Federal funds to
support hESC research became available on August 9, 2001, when President Bush
announced his decision regarding federal funding for hESC research.
Request a Discount on this report @
http://www.reportsnreports.com/contacts/discount.aspx?name=10600.
This market research report explores the complex IP landscape affecting development of
human embryonic stem cell products, providing clear guidance for companies entering or
already within the market, from collaborating with WARF to less costly alternatives - such as
circumventing the claims, conducting research off-shore, and developing embryonic stem
cell products for other species.
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
2© ReportsnReports.com / Contact sales@reportsandreports.com

3. Opportunities in Human
Embryonic Stem Cell Products
Key Findings Include:
•Trends for hESC Grants, Scientific Publications, and Patents
•Market Size Determination for the hESC Product Market
•5-Year Market Size Projections (2013-2017)
•Embryonic Stem Cell Patent Restrictions and Strategies to Circumvent Claims
•Geographical Breakdown (Leading Countries Conducting hESC Research)
•Breakdown of Embryonic Stem Cell Research, by Application and Species
•Competitive Analysis of hESC Research Supply Vendors
•Overview of Specialty Pharma Companies Developing Embryonic Stem Cell Therapies
•Overview of Toxicology Testing Legislation (impacting use of hESC in toxicology
applications)
•Crucial Trends and Unmet Market Needs
•And Much More
Complete report available @ http://www.reportsnreports.com/reports/10600-opportunities-
in-human-embryonic-stem-cell-hesc-products.html.
This report will help you understand the market entry challenges you face and give you the
expert advice to overcome them. Couple this with market leading intelligence data and this
report is a must have if you’re looking to outcompete your rivals in this expanding and
highly profitable market.
Order this report by calling +1 888 391 5441 or Send an email to
sales@reportsandreports.com with your contact details and questions if any.
3© ReportsnReports.com / Contact sales@reportsandreports.com